Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Breast Neoplasms 67Colorectal Neoplasms 36Central Nervous System Neoplasms 36Colonic Neoplasms 34Rectal Neoplasms 32Glioblastoma 23Gliosarcoma 20Carcinoma, Non-Small-Cell Lung 20Lung Neoplasms 18Stomach Neoplasms 16Pancreatic Neoplasms 15Sarcoma 14Ovarian Neoplasms 13Head and Neck Neoplasms 13Prostatic Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Neoplasm Metastasis 11Melanoma 11Astrocytoma 11Esophageal Neoplasms 10Carcinoma, Ovarian Epithelial 10Brain Neoplasms 10Uterine Cervical Neoplasms 9Kidney Neoplasms 9Fallopian Tube Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 9Breast Carcinoma In Situ 9Breast Neoplasms, Male 8Adenocarcinoma Of Esophagus 8Liver Neoplasms 7

Interventions

Watchful Waiting 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pancreatic Neuroendocrine Tumors (pNET) × Chemotherapy, Adjuvant × Clear all
NCT07591493 2026-05-15

ADJUPANET

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Not yet recruiting
300 enrolled
EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumors (pNET)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡